Inhibition of anti-Fas antibody-induced hepatitis by aminoguanidine in mice

被引:5
|
作者
Okamoto, T
Okabe, S
机构
[1] Nippon Chemiphar Co Ltd, Res Labs, Misato, Saitama 3410005, Japan
[2] Kyoto Pharmaceut Univ, Dept Appl Pharmacol, Kyoto 6078414, Japan
关键词
anti-Fas antibody; aminoguanidine; hepatitis;
D O I
10.1016/S0014-2999(00)00479-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aminoguanidine is an inhibitor of inducible nitric oxide synthase (iNOS) and is of potential clinical usefulness. Treatment of mice with anti-Fas antibodies (150 mu g/kg, i.v.) induced elevation of plasma alanine aminotransferase activity at 4 h and this elevation was inhibited by pretreatment of mice with aminoguanidine (3, 10 and 30 mg/kg, i.p.). The anti-Fas antibody-induced elevation of caspase-3 activity was inhibited by aminoguanidine (30 mg/kg, i.p.), but the addition of aminoguanidine to the cytosol up to 10(-4) M did not inhibit the caspase-3 activity in vitro. Thus, aminoguanidine prevents anti-Fas antibody-induced hepatitis by affecting the apoptotic pathway upstream of caspase-3 activation. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 50 条
  • [31] Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody
    Feng, GP
    Kaplowitz, N
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03): : 329 - 339
  • [32] The role of calcium signaling in anti-fas antibody induced apoptosis of Jurkat cells
    Scoltock, AB
    Bird, GSJ
    Putney, J
    Cidlowski, JA
    FASEB JOURNAL, 1999, 13 (07): : A1434 - A1434
  • [33] LETHAL EFFECT OF THE ANTI-FAS ANTIBODY IN MICE (VOL 364, PG 806, 1993)
    OGASAWARA, J
    WATANABEFUKUNAGA, R
    ADACHI, M
    MATSUZAWA, A
    KASUGAI, T
    KITAMURA, Y
    ITOH, N
    SUDA, T
    NAGATA, S
    NATURE, 1993, 365 (6446) : 568 - 568
  • [34] Platelets/thrombopoietin prevent acute liver failure induced by anti-Fas antibody
    Hisakura, K.
    Murata, S.
    Matsuo, R.
    Nakano, Y.
    Kawasaki, T.
    Kohno, K.
    Hashimoto, I.
    Shibasaki, Y.
    Ikeda, O.
    Myronovych, A.
    Watanabe, M.
    Ohkohchi, N.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S165 - S165
  • [35] Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-Fas ligand antibody therapy
    Nakamoto, Y
    Kaneko, S
    Fan, H
    Momoi, T
    Tsutsui, H
    Nakanishi, K
    Kobayashi, K
    Suda, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (08): : 1105 - 1111
  • [36] Yang-Gan-Wan protects mice against apoptosis induced by anti-fas antibody (Jo2)
    Yang, M
    Chen, K
    Shih, JC
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2000, 28 (3-4): : 325 - 330
  • [37] Inhibition of telomerase activity in renal cell carcinoma cells by doxorubicin and anti-Fas monoclonal antibody
    Jin, Xinghua
    Li, Yifei
    Li, Yongnan
    Jin, Chengluo
    Zhang, Jifei
    Liu, Jicheng
    MOLECULAR MEDICINE REPORTS, 2009, 2 (04) : 675 - 679
  • [38] Mechanisms of anti-GPIbα antibody-induced thrombocytopenia in mice
    Morodomi, Yosuke
    Kanaji, Sachiko
    Won, Eric
    Ruggeri, Zaverio M.
    Kanaji, Taisuke
    BLOOD, 2020, 135 (25) : 2292 - 2301
  • [39] Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody
    Chen, Delphine L.
    Zhou, Dong
    Chu, Wenhua
    Herrbrich, Phillip
    Engle, Jacquelyn T.
    Griffin, Elizabeth
    Jones, Lynne A.
    Rothfuss, Justin M.
    Geraci, Marco
    Hotchkiss, Richard S.
    Mach, Robert H.
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (01) : 137 - 144
  • [40] Protective effect of colchicine against TNFα- and anti-Fas antibody induced apoptosis.
    Feng, GP
    Kaplowitz, N
    HEPATOLOGY, 1999, 30 (04) : 390A - 390A